MedTrace Logo

Hepcidin Levels in Preterm Infants

NCT01539356 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 62

Last updated 2016-03-16

No results posted yet for this study

Summary

A recently isolated peptide hormone, hepcidin, is thought to be the principal regulator of iron homeostasis. Hepcidin acts by limiting intestinal iron absorption and promoting iron retention in reticuloendothelial cells. The aims of this study were to determine serum hepcidin levels in preterm infants who receive blood transfusion and preterm infants having sepsis, in order to assess possible relationships between hepcidin and serum iron, serum ferritin,in iron load situations.

Conditions

  • Preterm Infants
  • Anemia of Prematurity
  • Neonatal Sepsis

Sponsors & Collaborators

  • Meir Medical Center

    lead OTHER

Eligibility

Min Age
24 Weeks
Max Age
37 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2013-02-28
Completion
2013-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01539356 on ClinicalTrials.gov